1. Home
  2. EYPT vs SENEB Comparison

EYPT vs SENEB Comparison

Compare EYPT & SENEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • SENEB
  • Stock Information
  • Founded
  • EYPT 1987
  • SENEB 1949
  • Country
  • EYPT United States
  • SENEB United States
  • Employees
  • EYPT N/A
  • SENEB N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • SENEB Packaged Foods
  • Sector
  • EYPT Industrials
  • SENEB Consumer Staples
  • Exchange
  • EYPT Nasdaq
  • SENEB Nasdaq
  • Market Cap
  • EYPT 594.5M
  • SENEB 547.3M
  • IPO Year
  • EYPT 2005
  • SENEB N/A
  • Fundamental
  • Price
  • EYPT $7.48
  • SENEB $71.47
  • Analyst Decision
  • EYPT Strong Buy
  • SENEB
  • Analyst Count
  • EYPT 8
  • SENEB 0
  • Target Price
  • EYPT $25.71
  • SENEB N/A
  • AVG Volume (30 Days)
  • EYPT 922.9K
  • SENEB 324.0
  • Earning Date
  • EYPT 03-06-2025
  • SENEB 02-06-2025
  • Dividend Yield
  • EYPT N/A
  • SENEB N/A
  • EPS Growth
  • EYPT N/A
  • SENEB 23.82
  • EPS
  • EYPT N/A
  • SENEB 5.83
  • Revenue
  • EYPT $45,713,000.00
  • SENEB $1,482,656,000.00
  • Revenue This Year
  • EYPT N/A
  • SENEB N/A
  • Revenue Next Year
  • EYPT N/A
  • SENEB N/A
  • P/E Ratio
  • EYPT N/A
  • SENEB $12.16
  • Revenue Growth
  • EYPT 7.50
  • SENEB N/A
  • 52 Week Low
  • EYPT $6.90
  • SENEB $45.00
  • 52 Week High
  • EYPT $30.99
  • SENEB $79.80
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 44.49
  • SENEB 27.43
  • Support Level
  • EYPT $7.15
  • SENEB $76.01
  • Resistance Level
  • EYPT $8.25
  • SENEB $79.80
  • Average True Range (ATR)
  • EYPT 0.66
  • SENEB 0.06
  • MACD
  • EYPT -0.01
  • SENEB -0.95
  • Stochastic Oscillator
  • EYPT 22.01
  • SENEB 0.00

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About SENEB Seneca Foods Corp. Class B

Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.

Share on Social Networks: